United Therapeutics Chairperson & CEO Martine Rothblatt Executes Pre-Planned Option Exercise and Sale
UNITED THERAPEUTICS Corp
Subscribe to track UTHR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Alert: United Therapeutics ($UTHR)
**Insider:** Martine A. Rothblatt (Chairperson & CEO)
**Transaction Date:** September 4, 2026
**Type:** Stock Option Exercise & Sale (10b5-1 Plan)
**Details:**
- **Shares Sold:** 9,500
- **Average Sale Price:** ~$489.20
- **Gross Sale Value:** ~$4,647,354
- **Option Exercise Price:** $117.76 (Cost: ~$1,118,720)
- **Net Proceeds:** ~$3,528,634
- **Remaining Trust Holdings:** 324,443 shares (+ substantial direct and other trust holdings)
*Note: Executed pursuant to a pre-arranged Rule 10b5-1 plan adopted on November 7, 2025.*
Comprehensive Analysis
Executive Summary
On September 4, 2026, Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp ($UTHR), exercised 9,500 stock options at an exercise price of $117.76 per share and sold all 9,500 acquired shares of Common Stock in open-market transactions. The weighted-average selling price across several tranches was approximately $489.20, generating total proceeds of $4,647,354.42.
Transaction Details
- Derivative Exercise: Exercised 9,500 options expiring March 15, 2027, at $117.76 per share.
- Sales Breakdown:
- 40 shares @ $485.8455
- 223 shares @ $486.8783
- 2,818 shares @ $488.0760
- 3,425 shares @ $489.1236
- 1,514 shares @ $490.0092
- 1,160 shares @ $490.9351
- 320 shares @ $491.6925
- Plan Details: Conducted pursuant to a Rule 10b5-1 trading plan established on November 7, 2025.
Impact and Ownership Overview
Following these transactions, Rothblatt continues to hold 324,443 shares in the executing trust, 40,513 shares directly, and over 300,000 additional shares across other family trusts, in addition to 489,910 remaining derivative options in trust. Given the automated nature of the Rule 10b5-1 plan and routine option monetization prior to expiration, this transaction carries low informational signal for broader market sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.